Our previous study also demonstrated how β-HB supplementation ameliorates cisplatin-induced acute kidney injury (AKI) by inhibiting NLRP3 inflammasome activation and the cGAS-STING pathway [70]. The gene discussed is NLRP3; the disease is acute kidney injury.